 Home > Active Ingredient News > Antitumor Therapy > NMPA approves by BYVASDA (Bevadan antisimilar) for the treatment of relapsed glioblastoma

NMPA approves by BYVASDA (Bevadan antisimilar) for the treatment of relapsed glioblastoma

 Last Update: 2021-01-14
 Source: Internet
 Author: User

Tags

nattokinase cancer

styrene cancer

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Biopharmaceutical company Innovent Biologics recently announced that BYVASDA® has been officially approved by China's State Drug Administration (NMPA) for the treatment of reocgenerative glioblastoma (GBM, the most common malignant primary brain tumor), which is byVASDA® in China's third adaptation.
by byVASDA ® approved by China's State Drug Administration (NMPA) for the first time on June 17, 2020.
previously approved ® by BYVASDA include advanced non-small cell lung cancer and metastatic colorectal cancer.
the cancer burden in China has been increasing in recent years.
2018, 4.285 million new cancer diagnoses and 2.865 million cancer deaths in China, according to the World Health Organization's International Agency for Research on Cancer.
, glioblastoma is the most common and invasive brain malignancy, characterized by high morbidity, high recurrence, high mortality and low cure rate.
current treatment options for glioblastoma include surgical excision, radiotherapy and chemotherapy.
survival time is only 12 to 15 months, and there has been no significant change over the past decade.
, glioblastoma patients urgently need more new treatments.
。

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Crocetin27876-94-4

CAS No.: 27876-94-4

$1-1.1/G FOB

Betulinic acid472-15-1

CAS No.: 472-15-1

$1-1.1/G FOB

1-(2-chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane 53-19-0

CAS No.: 53-19-0

Pharmacy Grade

$100/KG EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.